Heart attack

Evan Smith
October 22, 2018 - 4:22 pm
State Rep. Mike Pitts is recovering after suffering a heart attack over the weekend. Pitts was hospitalized after suffering a heart attack Saturday while on a hunting trip in Montana. Pitts underwent surgery at a hospital in Missoula, Montana. He is doing well and expected to make a full recovery...
Read More
October 12, 2018 - 4:20 am
COLUMBIA, S.C. (AP) — A South Carolina high school football coach says one of his players has suffered a heart attack while playing at an off-campus pickup basketball game. Richland Northeast High School coach Bennett Weigle tells The State a group of firefighters was nearby and performed CPR on...
Read More
This undated product image provided by Sanofi shows Praluent 75 mg, a drug sold by Sanofi and Regeneron Pharmaceuticals. It’s one of a new class of cholesterol medicines that lower cholesterol far more than statin medicines can. A key study tested whether it also reduces heart attack risks and deaths. (Sanofi via AP)
March 10, 2018 - 10:40 am
ORLANDO, Fla. (AP) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent (PRALL-yoo-ent), were announced...
Read More
FILE - In a Saturday, July 9, 2016 file photo, Kevin Smith arrives at the Los Angeles premiere of "Ghostbusters" at the TCL Chinese Theatre. The actor-director Kevin Smith says he had a “massive” heart attack after performing at a Los Angeles comedy show Sunday night, Feb. 25, 2018. Early Monday morning, Smith said on Twitter that if he hadn’t canceled his second show Sunday and gone to the hospital, he would have died.(Photo by Jordan Strauss/Invision/AP, File)
February 26, 2018 - 9:38 am
NEW YORK (AP) — Actor-director Kevin Smith says he had a "massive" heart attack after performing at a Los Angeles comedy show Sunday night. Smith said on Twitter early Monday morning that if he hadn't canceled his second show Sunday and gone to the hospital, he would have died. Smith credited a...
Read More
December 25, 2017 - 12:42 am
NEW YORK (AP) — The oldest daughter of a New York City man killed by a police chokehold has been hospitalized in critical condition after suffering a heart attack. Family members tell the Daily News that 27-year-old Erica Garner went into cardiac arrest Saturday night. The woman's father, Eric...
Read More
In this Wednesday, Nov. 15, 2017, photo, Brad Sippy, chief executive officer of Tremeau Pharmaceuticals, Inc., stands for a portrait in Cambridge, Mass. Tremeau Pharmaceuticals, Inc., is a small startup trying to bring the recalled painkiller Vioxx back to the market. They are seeking FDA approval for patients with hemophilia with severe pain, but once on the market, doctors could go back to prescribing it to anyone with pain. (AP Photo/Steven Senne)
November 21, 2017 - 6:12 am
TRENTON, N.J. (AP) — Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau...
Read More
FILE - In this Jan. 3, 2012, file photo, former Pennsylvania Gov. and former Homeland Security Secretary Tom Ridge introduces Republican presidential candidate former Utah Gov. Jon Huntsman during a campaign event, in Peterborough, N.H. Ridge was in critical condition Thursday, Nov. 16, 2017, after undergoing an emergency heart procedure at a hospital in Austin. (AP Photo/Matt Rourke, File)
November 17, 2017 - 11:36 am
AUSTIN, Texas (AP) — The wife of former U.S. Homeland Security Secretary Tom Ridge says he's in the early stages of recovery from a heart attack, a day after undergoing an emergency heart procedure. The 72-year-old Ridge remained hospitalized in critically stable condition Friday in Austin, Texas,...
Read More
FILE - This Thursday, Dec.18, 2014, file photograph, shows the Merck logo on a stained glass panel at a Merck company building in Kenilworth, N.J. A new type of cholesterol drug meant to prevent heart attacks and other complications clearly did so, in an unusually large study whose results were announced Tuesday, Aug. 29, 2017, at a conference of heart specialists. But the daily pill only reduced those complications by 9 percent, leaving drugmaker Merck with a tough call on whether to seek regulatory approval after spending 13 years and likely hundreds of millions of dollars on testing. (AP Photo/Mel Evans, File)
August 29, 2017 - 2:35 am
TRENTON, N.J. (AP) — So-so results for a new type of cholesterol drug have left Merck in a quandary: Does the company try to bring it to market or scrap it? A large, long-term study of the drug showed that it prevents heart attacks and reduces the need for heart procedures, while three similar...
Read More
FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. According to results published Sunday, Aug. 27, 2017, for the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, which has been the main focus for decades. Canakinumab's maker, Novartis, sponsored the study. (Georgios Kefalas/Keystone via AP, File)
August 27, 2017 - 5:03 am
For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an...
Read More
FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. According to results published Sunday, Aug. 27, 2017, for the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, which has been the main focus for decades. Canakinumab's maker, Novartis, sponsored the study. (Georgios Kefalas/Keystone via AP, File)
August 27, 2017 - 5:00 am
For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol. Many heart attacks occur in people who have normal cholesterol but high inflammation, which can lead to clogged arteries. A study tested the Novartis...
Read More

Pages